Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting
Launched by GUSTAVE ROUSSY, CANCER CAMPUS, GRAND PARIS · Mar 24, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed patient and signed informed consent
- • Age equal or greater than 18
- • Speak and read french
- • For serum holder connected to wheelchair only : patients with multiple infusion devices and transported in wheelchair
- • For wheelchair seat : patients transported in wheelchair from hospitalized unit to radiology department
- Exclusion Criteria:
- • disoriented or confused patient
- • Patients under judicial protection (curatorship, tutorship) and/or deprived of freedom
- • pregnant or breastfeeding women
About Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, located within the Cancer Campus in Grand Paris, is a leading European cancer center renowned for its commitment to innovative cancer research, comprehensive patient care, and advanced treatment methodologies. As a prominent clinical trial sponsor, Gustave Roussy focuses on enhancing therapeutic options and improving outcomes for cancer patients through cutting-edge clinical investigations. The institution fosters collaboration among multidisciplinary teams of experts, leveraging state-of-the-art technologies and a patient-centered approach to drive forward the frontiers of oncology research and treatment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Villejuif, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
